Van Den Berg Management I Inc. decreased its position in Danaher Co. (NYSE:DHR) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 109,330 shares of the conglomerate’s stock after selling 1,590 shares during the period. Van Den Berg Management I Inc.’s holdings in Danaher were worth $10,148,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the stock. Teachers Insurance & Annuity Association of America bought a new position in Danaher in the fourth quarter valued at about $640,000. Stone Ridge Asset Management LLC acquired a new position in Danaher in the fourth quarter valued at about $470,000. Kendall Capital Management acquired a new position in Danaher in the fourth quarter valued at about $368,000. Guggenheim Capital LLC lifted its stake in Danaher by 0.9% in the fourth quarter. Guggenheim Capital LLC now owns 880,069 shares of the conglomerate’s stock valued at $81,686,000 after buying an additional 7,641 shares during the period. Finally, QS Investors LLC lifted its stake in Danaher by 3.0% in the fourth quarter. QS Investors LLC now owns 28,849 shares of the conglomerate’s stock valued at $2,678,000 after buying an additional 851 shares during the period. Institutional investors and hedge funds own 77.83% of the company’s stock.
In related news, insider Rainer Blair sold 3,981 shares of Danaher stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $100.05, for a total value of $398,299.05. Following the sale, the insider now owns 49,751 shares of the company’s stock, valued at approximately $4,977,587.55. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP William K. Daniel sold 131,066 shares of Danaher stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $102.05, for a total value of $13,375,285.30. Following the completion of the sale, the executive vice president now directly owns 270,523 shares in the company, valued at approximately $27,606,872.15. The disclosure for this sale can be found here. In the last three months, insiders sold 313,260 shares of company stock worth $31,657,786. 12.20% of the stock is owned by insiders.
Danaher Co. (NYSE DHR) traded down $0.37 during midday trading on Monday, hitting $103.37. The stock had a trading volume of 136,364 shares, compared to its average volume of 2,651,634. The firm has a market capitalization of $72,160.00, a price-to-earnings ratio of 29.55, a P/E/G ratio of 2.18 and a beta of 1.04. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.05 and a current ratio of 1.43. Danaher Co. has a 52 week low of $78.97 and a 52 week high of $104.82.
Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The company had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. During the same quarter last year, the firm posted $1.05 earnings per share. Danaher’s revenue was up 10.9% compared to the same quarter last year. analysts anticipate that Danaher Co. will post 4.37 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date of this dividend is Wednesday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.14. Danaher’s dividend payout ratio (DPR) is currently 16.00%.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.